Please provide your email address to receive an email when new articles are posted on . New therapies, like drugs for glomerular diseases and kidney replacement devices, offer potential for treating ...
On the first day of ASN 2025 Kidney Week, Dr Sumeska Thavarajah reports on several clinical trials in kidney disease that were presented, notably including a phase 2 study of rilparencel, a stem cell ...
Please provide your email address to receive an email when new articles are posted on . Disease remission is now achievable, and cure might be on the horizon, according to a speaker at ASN Kidney Week ...
Interim results from a phase III trial were presented at the Kidney Week meeting ...
Six new studies from DaVita Clinical Research spotlight improved outcomes with GLP-1 use, advancements in treatments, transplant access and end-of-life care DENVER and HOUSTON, Nov. 4, 2025 ...
After attending the ASN 2025 Kidney Week, Dr Sumeska Thavarajah reflects on the exciting developments in nephrology, particularly the emergence of new drugs entering advanced clinical trials. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results